Risk Factors
431 articles
Let’s Win! Pancreatic Cancer Foundation Appoints Two New Board Members
David Glauber and Sergeant Elvin Howard, Jr., have been appointed to the Let’s Win Board of Directors, effective July 2020.
COVID-19—An Update
What is the status of international and US travel? Which states have mask mandates? Are vaccines progressing? Read our COVID-19 update for more information.
Families Working Together Against Pancreatic Cancer
Rob Greenstein discusses how Let’s Win helped his family after his sister Jackie was diagnosed with pancreatic cancer.
Let’s Win Turns 5!
Let’s Win has reached its 5th anniversary! We have grown, with more than 500 original stories about treatments and trials to help patients.
LET’S WIN! PANCREATIC CANCER Turns 5!
Let’s Win has reached its 5th anniversary. Read about our development and what we have accomplished in 5 short years.
PancChat Featured in a Journal Article
PancChat co-host Dr. Niraj Gusani has coauthored an article about the advantages of social media for oncology surgeons.
Let’s Learn Webinar on Clinical Trials on October 28th
Join Let’s Win for a webinar on the Importance of Clinical Trials, to learn more about participating in a trial as part of treatment.
For Tommy Thompson, the Commitment to Pancreatic Cancer Research Is Personal
Former Wisconsin Governor Tommy Thompson is an advocate for pancreatic cancer research because he lost both his brothers to the disease.
AI Platform Reveals Hidden Biology of Tumor Formation
Dr. Laura Wood and colleagues are developing an artificial intelligence (AI) platform to identify tumors as they are forming.
ASCO 2023: Pancreatic Cancer Research Update
The pancreatic cancer research reports from ASCO 2023 focused on different chemotherapy combinations, including immunotherapy.
Using Ice to Prevent Neuropathy
Neuropathy–tingling or numbness in your extremities–is a common side effect of chemotherapy. Learn more about the role of ice in preventing neuropathy.
Higher Glucose Levels May Improve Chemotherapy Effectiveness
Can higher glucose levels make chemotherapy more effective? Dr. Jordan Winter and colleagues are studying the relationship.
Two-Drug Combo Targets KRAS and Fights Resistance
Researcher Hervé Tiriac leads a clinical trial for a new drug combination targeting KRAS and chemotherapy resistance.